Literature DB >> 1964683

Transforming growth factor-beta receptors and binding proteoglycans.

F T Boyd1, S Cheifetz, J Andres, M Laiho, J Massagué.   

Abstract

Transforming growth factors-beta (TGFs-beta) are representative of a superfamily whose members were first identified as regulators of morphogenesis and differentiation, and subsequently found to be structurally related. Other members of the family include the activins and inhibins, BMPs, MIS, the DPP-C gene product and Vg-1. When assayed by affinity-labelling techniques, TGFs-beta bind to three distinct cell surface proteins which are present on most cells. These proteins are all of relatively low abundance but bind TGFs-beta with affinities consistent with the biological potency of the factors. The Type I and Type II binding proteins are glycoproteins with estimated molecular weights of 53 and 73 x 10(3) Mr, respectively. They both bind TGF-beta 1 significantly better than TGF-beta 2. The Type I receptor has been identified as the receptor which mediates many of the responses of TGFs-beta, based on somatic cell genetic studies of epithelial cell mutants unresponsive to TGFs-beta. Betaglycan is the third binding protein present on many, but not all, cell types and is a large proteoglycan (approximately 280 x 10(3) Mr) with 100-120 x 10(3) Mr core proteins. A soluble form of this molecule is present in conditioned media of many cell lines and may be derived from the cell surface-associated molecule by cleavage of a small membrane anchor. Betaglycan binds TGF-beta 1 and TGF-beta 2 with similar affinity and this binding is to the core proteins, not the glycosaminoglycan side chains. This molecule may have a function in the localization and delivery or the clearance of activated TGFs-beta.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1964683     DOI: 10.1242/jcs.1990.supplement_13.12

Source DB:  PubMed          Journal:  J Cell Sci Suppl        ISSN: 0269-3518


  11 in total

1.  Intact aggrecan and fragments generated by both aggrecanse and metalloproteinase-like activities are present in the developing and adult rat spinal cord and their relative abundance is altered by injury.

Authors:  M L Lemons; J D Sandy; D K Anderson; D R Howland
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

Review 2.  Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects.

Authors:  Ian Toma; Timothy A McCaffrey
Journal:  Cell Tissue Res       Date:  2011-05-31       Impact factor: 5.249

3.  Heterogeneous engineered cartilage growth results from gradients of media-supplemented active TGF-β and is ameliorated by the alternative supplementation of latent TGF-β.

Authors:  Michael B Albro; Robert J Nims; Krista M Durney; Alexander D Cigan; Jay J Shim; Gordana Vunjak-Novakovic; Clark T Hung; Gerard A Ateshian
Journal:  Biomaterials       Date:  2015-11-18       Impact factor: 12.479

Review 4.  Heparan sulfate proteoglycans: a GAGgle of skeletal-hematopoietic regulators.

Authors:  Kathryn D Rodgers; James D San Antonio; Olena Jacenko
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

5.  TGF-beta3 and TNFalpha perturb blood-testis barrier (BTB) dynamics by accelerating the clathrin-mediated endocytosis of integral membrane proteins: a new concept of BTB regulation during spermatogenesis.

Authors:  Weiliang Xia; Elissa W P Wong; Dolores D Mruk; C Yan Cheng
Journal:  Dev Biol       Date:  2008-12-07       Impact factor: 3.582

6.  Evidence for an age-related dysfunction in the antiproliferative response to transforming growth factor-beta in vascular smooth muscle cells.

Authors:  T A McCaffrey; D J Falcone
Journal:  Mol Biol Cell       Date:  1993-03       Impact factor: 4.138

7.  Specific stimulation of basal lamina heparan sulfate proteoglycan in mouse uterine epithelium by Matrigel and by transforming growth factor-beta 1.

Authors:  J E Morris; G Gaza; S W Potter
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-02       Impact factor: 2.416

8.  Growth hormone mRNA in mammary gland tumors of dogs and cats.

Authors:  J A Mol; E van Garderen; P J Selman; J Wolfswinkel; A Rijinberk; G R Rutteman
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

9.  Shearing of synovial fluid activates latent TGF-β.

Authors:  M B Albro; A D Cigan; R J Nims; K J Yeroushalmi; S R Oungoulian; C T Hung; G A Ateshian
Journal:  Osteoarthritis Cartilage       Date:  2012-07-31       Impact factor: 6.576

Review 10.  Transforming growth factor Beta family: insight into the role of growth factors in regulation of fracture healing biology and potential clinical applications.

Authors:  Łukasz A Poniatowski; Piotr Wojdasiewicz; Robert Gasik; Dariusz Szukiewicz
Journal:  Mediators Inflamm       Date:  2015-01-29       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.